Bruno Almeida Costa

15PUBLICATIONS
46CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyHaematological tumoursMedical roboticsDisease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Feb 26, 2025
Impact of Prior Selinexor Exposure on Outcomes of Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Multiple Myeloma: An Exploratory Analysis.

Bruno Almeida Costa, Danai Dima, Tomer Mark

|May 31, 2024
Comparison of infectious complications with BCMA-directed therapies in multiple myeloma.

Karthik Nath, Tala Shekarkhand, David Nemirovsky

|May 27, 2024
Prognostic impact of corticosteroid and tocilizumab use following chimeric antigen receptor T-cell therapy for multiple myeloma.

Bruno Almeida Costa, Jessica Flynn, Noriko Nishimura

|Apr 12, 2024
Comparative efficacy of carfilzomib, lenalidomide, and dexamethasone (KRd) versus bortezomib, lenalidomide, and dexamethasone (VRd) in newly-diagnosed multiple myeloma: A systematic review and meta-analysis.

Bruno Almeida Costa, Thomaz Alexandre Costa, Kevin Pak

|Mar 15, 2024
Thromboembolic risk of carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for newly diagnosed multiple myeloma: A comparative systematic review and meta-analysis.

Bruno Almeida Costa, Thomaz Alexandre Costa, Sara Diaz Saravia

|Feb 26, 2024
Comparison of Infectious Complications with BCMA-directed Therapies in Multiple Myeloma.

Alexander Lesokhin, Karthik Nath, Tala Shekarkhand

Pageof 3

Frequent Collaborators

7 joint publications

Carlyn Rose Tan

7 joint publications

Neha Korde

6 joint publications

Saad Z Usmani

6 joint publications

Gunjan Shah